Related Experiment Video

Updated: Sep 3, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.9K

A Bibliometric and Visualized Analysis of Uremic Cardiomyopathy From 1990 to 2021

Jing-Fu Bao1,2, Pan-Pan Hu1,2, Qin-Ying She3

  • 1State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Frontiers in Cardiovascular Medicine
|July 29, 2022
PubMed

Insights

This bibliometric analysis of uremic cardiomyopathy research reveals key trends over 30 years. Future studies may focus on phosphate metabolism and novel biomarkers for chronic kidney disease patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Bibliometrics

Background:

  • Uremic cardiomyopathy is a significant complication of chronic kidney disease (CKD), impacting patient prognosis.
  • Research on uremic cardiomyopathy has advanced rapidly but lacks a comprehensive overview.
  • This study provides a bibliometric analysis of uremic cardiomyopathy research over the past three decades.

Purpose of the Study:

  • To evaluate the research landscape of uremic cardiomyopathy over the last 30 years.
  • To identify key topics, significant achievements, and emerging trends in the field.
  • To provide insights for future research directions.

Main Methods:

  • Bibliometric analysis of 2,403 publications from Science Citation Index Expanded.
  • Utilized HistCite, VOSviewer, CiteSpace, and Bibliometrix Package for data analysis and visualization.
  • Analyzed publication trends, leading countries, institutions, authors, journals, and keywords.

Main Results:

  • The United States leads in productivity and citations; nephrology journals are central.
  • Phosphate metabolism and the fibroblast growth factor-23-klotho axis are current research hotspots.
  • Research output has plateaued in the last three years.

Conclusions:

  • The US and Europe are central to uremic cardiomyopathy research; increased Chinese involvement is suggested.
  • Future research may concentrate on endogenous natriuretic factors and novel biomarkers.
  • The field is maturing, with established hotspots and emerging areas.
Abstract

Keywords:
CiteSpaceHistCiteVOSviewerbibliometric analysisbibliometrixuremic cardiomyopathy

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.4K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

742

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
76
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
47
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
40
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56